Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

7.1%

1 terminated/withdrawn out of 14 trials

Success Rate

92.9%

+6.4% vs industry average

Late-Stage Pipeline

79%

11 trials in Phase 3/4

Results Transparency

15%

2 of 13 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 3

10(71.4%)

Phase 2

2(14.3%)

Phase 4

1(7.1%)

Phase 1

1(7.1%)

14Total

Phase 3(10)

Phase 2(2)

Phase 4(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials

NCT00634166Phase 4Terminated

Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group

Role: collaborator

NCT00142584Phase 3Completed

Evaluation of the Long-term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension

Role: lead

NCT00145210Phase 3Completed

Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African Americans

Role: lead

NCT00200512Phase 2Completed

Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months

Role: lead

NCT00200421Phase 2Completed

A Pilot Study Comparing Nebivolol and Atenolol and Its Effects With Exercise in Patients With Mild to Moderate Hypertension

Role: lead

NCT00200499Phase 3Completed

A Study of the Safety and Efficacy of Long-Term Nebivolol Use in Hypertensive Patients

Role: lead

NCT00200525Phase 3Completed

Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease

Role: lead

NCT00200434Phase 3Completed

A Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in Patients With Hypertension

Role: lead

NCT00200473Phase 3Completed

A Study of the Safety and Efficacy of Nebivolol in Hypertensive Patients

Role: lead

NCT00200460Phase 3Completed

A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive Patients

Role: lead

NCT00145236Phase 3Completed

Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate Hypertension

Role: lead

NCT00158093Phase 1Completed

A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or Placebo

Role: lead

NCT00145171Phase 3Completed

A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.

Role: lead

NCT00142545Phase 3Completed

Long Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes in Late-Stage Parkinson's Disease

Role: lead

All 14 trials loaded